Supplements and Featured Publications

Therapeutic Updates in Myelofibrosis
This publication spans multiple updates regarding systemic treatment for patients with myelofibrosis, as well as expert insights in video format covering how they approach their patients with newly available agents.

My Treatment Approach: Colorectal Cancer
This publication covers some of the latest advances in colorectal cancer treatment following recent read outs from clinical trials, as well as expert insights on how they approach therapy on an individualized basis.

Emerging Treatments and Clinical Challenges in Myelodysplastic Syndromes: ASCO 2021 and EHA 2021 Updates
This publication features research that was presented in myelodysplastic syndromes from the 2021 ASCO Annual Meeting and 2021 EHA Congress, including expert perspectives on how the data have clinical implications.
Sponsored by Takeda Oncology/Content Developed Independently by OncLive

ASCO 2021: Updates in Myeloproliferative Neoplasms
This publication covers a multitude of presentations in myeloproliferative neoplasms that were presented and discussed during the 2021 ASCO Annual Meeting.

ASCO 2021: Updates in Genitourinary Cancers
This publication provides coverage of data in genitourinary cancers that were presented at the 2021 ASCO Annual Meeting.

My Treatment Approach: Lung Cancer Practice Patterns

The Evolving Role of Immunotherapy in Metastatic Non–Small Cell Lung Cancer

2021 EBMT Annual Meeting
Coverage of the 2021 EBMT Annual Meeting, held virtually March 14-17, 2021.

Defining Value for the Treatment of Brain Metastases in Metastatic HER2-Positive Breast Cancer

2021 Genitourinary Cancers Symposium

2021 Gastrointestinal Cancers Symposium

Updates in NRG1+ Tumors

My Treatment Approach: BRAF+ Melanoma

ASH 2020: CAR T-Cell Therapy Updates

Frontline Immunotherapy Updates in Advanced NSCLC

Year in Review: HER2+ Updates in Oncology

Updates in Relapsed/Refractory AML

Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 2

Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 1

Updates and Advances in Basal Cell Carcinoma

SABCS 2020: Reflections in HER2+ Breast Cancer

Current and Emerging Trends in Chronic Myeloid Leukemia

My Treatment Approach: Locally Advanced Lung Cancer

Utilizing Tumor Metabolism in Solid Malignancies

Updates in ESR1-Mutant Breast Cancer

My Treatment Approach: Multiple Myeloma

My Treatment Approach: Chronic Lymphocytic Leukemia

Advances in Immunotherapy in Metastatic Non–Small Cell Lung Cancer

Role of Trop-2 as an Actionable Biomarker in Solid Tumors


